Physician profile
Charles L Getz
NPI 1063440527
$1,089,632.14
in general payments reported to CMS, 2019-2025
15 companies · $355K in 2025
The $355K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $21K · 2021: $33K · 2022: $149K · 2023: $217K · 2024: $282K · 2025: $355K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $711K · Education: $67K · Consulting Fee: $62K · Travel and Lodging: $12K · Food and Beverage: $2,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $711,014.48 |
| Education | $66,895.00 |
| Consulting Fee | $61,650.00 |
| Travel and Lodging | $11,596.05 |
| Food and Beverage | $2,911.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,088,650.67 | 2019-2025 | Identity, Comprehensive Shoulder System, Biowick X |
| Stryker Corporation | $180.66 | 2019-2022 | |
| Catalyst Orthoscience | $167.85 | 2019 | |
| Exactech, INC. | $156.20 | 2022 | |
| Davol INC. | $144.60 | 2021-2024 | |
| Medtronic, INC. | $66.32 | 2023-2024 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $59.84 | 2020 | |
| Orthofix Medical, INC. | $39.19 | 2024 | Spinal-Stim, Cervical-Stim |
| Smith+Nephew, INC. | $38.99 | 2021 | |
| Paladin Technology Solutions | $36.52 | 2023-2025 | |
| Dynasplint Systems INC. | $25.03 | 2019 | |
| Ermi LLC | $21.37 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.35 | 2025 | |
| Amgen INC. | $16.45 | 2019 | |
| Acumed LLC | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Getz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.